Basilea gibt Markteinführung des Antibiotikums Zevtera (Ceftobiprol) in Kanada durch Avir Pharma bekannt

NEXT STORY
Enzymatica AB: Ny ColdZyme-studie på elitidrottare bekräftar förebyggande och förkortande effekt
PREV STORY
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Capital Senior Living Corporation Reports First Quarter 2020 Results

author_avatar
NASDAQ Market News

TG Therapeutics Announces Data from a Phase 1 Study Evaluating TG-1701 as a Monotherapy and as a Triple Combination with Ublituximab and UKONIQ® at the 2021 European Hematology Association Virtual Congress

author_avatar
NASDAQ Market News

Arcutis Provides Update on Phase 2a Clinical Trial Evaluating ARQ-252 Cream as a Potential Treatment for Vitiligo

author_avatar
NASDAQ Market News